tiprankstipranks
Trending News
More News >
Arrail Group Ltd. (HK:6639)
:6639
Hong Kong Market
Advertisement

Arrail Group Ltd. (6639) AI Stock Analysis

Compare
1 Followers

Top Page

HK:6639

Arrail Group Ltd.

(6639)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
HK$2.00
▲(16.96% Upside)
The overall stock score of 52 reflects a combination of mixed financial performance and bearish technical indicators. While cash flow and profitability have shown improvement, the stock's technical analysis indicates a bearish trend, and the valuation suggests potential overvaluation. The absence of earnings call data and corporate events limits additional insights.
Positive Factors
Cash Flow Management
Strong cash flow management indicates the company's ability to generate cash efficiently, supporting long-term operations and investments.
Balance Sheet Stability
A stable debt-to-equity ratio suggests financial prudence, providing resilience against economic fluctuations and supporting growth initiatives.
Profitability Improvement
Improved profitability reflects effective cost management and operational efficiency, enhancing the company's financial health and sustainability.
Negative Factors
Revenue Growth Challenges
Inconsistent revenue growth can hinder long-term expansion and market competitiveness, necessitating strategic adjustments to drive sales.
Operational Efficiency
Decreasing gross margins suggest challenges in maintaining cost efficiency, potentially impacting profitability and competitive positioning.
Mixed Financial Performance
Mixed financial performance highlights the need for strategic focus on enhancing revenue streams and operational processes to ensure sustainable growth.

Arrail Group Ltd. (6639) vs. iShares MSCI Hong Kong ETF (EWH)

Arrail Group Ltd. Business Overview & Revenue Model

Company DescriptionArrail Group Ltd. (6639) is a leading provider of dental and healthcare services in China, primarily focusing on high-quality dental care and related services. The company operates a network of dental clinics and facilities, offering a range of services including orthodontics, cosmetic dentistry, dental implants, and preventive care. With a commitment to delivering exceptional patient care and leveraging advanced technology, Arrail Group aims to set a benchmark in the dental industry while expanding its footprint across various regions in China.
How the Company Makes MoneyArrail Group generates revenue primarily through its dental services, which include consultations, treatments, and preventive care for patients. The company's revenue model is based on a fee-for-service structure, where patients pay for individual treatments or packages offered by the clinics. Key revenue streams include orthodontic treatments, cosmetic procedures, dental implants, and routine check-ups. The company also benefits from partnerships with insurance providers, which can enhance patient access to services and potentially increase the volume of patients served. Additionally, Arrail Group may engage in strategic collaborations with suppliers of dental materials and equipment, which can also contribute to cost efficiencies and revenue generation.

Arrail Group Ltd. Financial Statement Overview

Summary
Arrail Group Ltd. shows a mixed financial performance. Profitability and cash flow have improved, but revenue growth and operational efficiency present challenges. The balance sheet is stable, with manageable leverage and a solid asset base. Continued focus on cost management and revenue growth will be crucial for enhancing financial performance.
Income Statement
55
Neutral
The income statement shows a mixed performance. Gross profit margin has slightly decreased over the years, indicating some pressure on cost management. The net profit margin has improved from negative to positive, showing a recovery in profitability. However, the revenue growth rate has been inconsistent, with a recent decline of 3.36%. The EBIT and EBITDA margins are stable but not particularly strong, suggesting room for operational efficiency improvements.
Balance Sheet
60
Neutral
The balance sheet reflects a moderate financial position. The debt-to-equity ratio is stable at around 0.6, indicating manageable leverage. Return on equity has improved but remains low, suggesting limited profitability relative to shareholder equity. The equity ratio is healthy, showing a solid asset base relative to liabilities. Overall, the company maintains a stable but not overly strong financial structure.
Cash Flow
65
Positive
Cash flow analysis reveals positive trends. Free cash flow growth has been strong recently, and the free cash flow to net income ratio is robust, indicating good cash generation relative to earnings. The operating cash flow to net income ratio is moderate, suggesting that cash flow from operations is supporting profitability. Overall, cash flow management appears to be a strength for the company.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.75B1.69B1.75B1.47B1.62B1.52B
Gross Profit364.84M342.09M392.68M247.08M336.56M364.42M
EBITDA93.34M312.65M322.35M87.85M42.10M-300.84M
Net Income20.83M21.99M17.16M-219.91M-701.03M-599.42M
Balance Sheet
Total Assets3.13B3.16B3.25B3.06B2.99B2.35B
Cash, Cash Equivalents and Short-Term Investments997.94M1.09B1.10B937.53M1.26B727.31M
Total Debt1.05B1.03B1.05B955.68M890.67M1.03B
Total Liabilities1.39B1.38B1.42B1.37B1.38B4.81B
Stockholders Equity1.67B1.71B1.76B1.61B1.56B-2.50B
Cash Flow
Free Cash Flow172.32M172.69M184.21M23.50M108.63M213.50M
Operating Cash Flow217.17M231.14M276.65M131.66M224.28M242.87M
Investing Cash Flow74.11M-153.52M-176.00M-342.44M-203.94M61.75M
Financing Cash Flow-274.06M-206.84M-106.96M-280.35M380.86M217.51M

Arrail Group Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.71
Price Trends
50DMA
1.96
Negative
100DMA
2.17
Negative
200DMA
2.19
Negative
Market Momentum
MACD
-0.09
Positive
RSI
41.27
Neutral
STOCH
27.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6639, the sentiment is Neutral. The current price of 1.71 is below the 20-day moving average (MA) of 1.79, below the 50-day MA of 1.96, and below the 200-day MA of 2.19, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 41.27 is Neutral, neither overbought nor oversold. The STOCH value of 27.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:6639.

Arrail Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$1.05B13.846.35%1.96%-1.61%-27.39%
68
Neutral
HK$1.78B9.347.31%9.80%-3.19%-20.30%
65
Neutral
HK$6.92B23.5731.23%1.98%28.53%22.34%
55
Neutral
HK$6.59B-6.32-9.67%2.52%-8.56%-403.12%
52
Neutral
HK$1.10B42.301.27%-4.30%13.83%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
HK$2.17B-6.41%1.16%2.05%-285.88%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6639
Arrail Group Ltd.
1.75
-1.32
-43.00%
HK:1846
EuroEyes International Eye Clinic Limited
3.13
-0.94
-23.10%
HK:1951
Jinxin Fertility Group Ltd.
2.39
-0.60
-20.07%
HK:2219
Chaoju Eye Care Holdings Ltd.
2.56
-0.22
-7.91%
HK:2373
Beauty Farm Medical & Health Industry, Inc.
24.30
7.46
44.30%
HK:3309
C-MER Eye Care Holdings Limited
1.73
-0.28
-13.93%

Arrail Group Ltd. Corporate Events

Arrail Group Limited AGM Approves Key Resolutions
Sep 26, 2025

Arrail Group Limited, a company incorporated in the British Virgin Islands and continued in the Cayman Islands, held its Annual General Meeting on September 26, 2025. During the meeting, all proposed resolutions were approved by shareholders, including the adoption of financial statements, re-election of directors, and the appointment of auditors. The meeting also granted the board mandates to issue and repurchase shares, reflecting strong shareholder support for the company’s governance and strategic decisions.

The most recent analyst rating on (HK:6639) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Arrail Group Ltd. stock, see the HK:6639 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025